Itch
Conditions
Keywords
itchy skin diseases, itch treatments, pruriception
Brief summary
This study is to investigate the pruriception (i.e. the perception of the character and intensity of itch), the impact of itch on quality of life, the response to itch and the subjective efficacy and preferences of the different treatment options among patients with different skin diseases. Better insights into these aspects might help to optimize itch treatment in clinical Settings.
Interventions
OTHERSurvey on itch
self-administered patient questionnaire regarding the different aspects of itch
Sponsors
University Hospital, Basel, Switzerland
Study design
Observational model
COHORT
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* outpatients suffering from itch
Exclusion criteria
* outpatients (suffering from itch) not willing or able to participate
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| itch intensity | single time point assessment at baseline | Questions regarding itch perception (NRS 0-10; 0 = no itch, 10 = worst imaginable itch) experienced at the moment, within the last 7 days, within the last month |
| itch perception | single time point assessment at baseline | Questions regarding situations in which the itch is especially bad (multiple choice options regarding day time, daily situations, season); objective assessment in which respondents are asked to select answers from the choices offered as a list |
| impact of itch on quality of life | single time point assessment at baseline | Questions regarding strength of impact of itch on quality of life (NRS 0-10; 0 = no impact, 10 = extreme) |
| quality of sleep | single time point assessment at baseline | Questions regarding sleep disturbance by itch (Does itch disturb the patient's sleep and/or sleep of other persons? (yes/no)) |
| days missing at work | single time point assessment at baseline | Approximate number of days missing at work due to itch within last 6 months |
| helpfulness of common itch therapies | single time point assessment at baseline | Questions regarding helpfulness of common itch therapies (NRS 0-10; 0 = no reduction in itch, 10 = complete reduction of itch; additionally free text options to indicate specific creams, tablets or alternative medicine) |
| preferred treatment options | single time point assessment at baseline | Questions regarding preferred treatment options (NRS 0- 10; 0 = unimportant, 10 = most important; including additional free text option) |
Countries
Switzerland
Outcome results
None listed